Sustained release ranolazine formulations

Details for Australian Patent Application No. 2008207703 (hide)

Owner Roche Palo Alto, LLC

Inventors Wolff, Andrew A; Baker, Fiona; Langridge, John

Agent Freehills

Pub. Number AU-A-2008207703

Priority 09/321,522 27.05.99 US; 60/099,804 10.09.98 US

Filing date 3 September 2008

Wipo publication date 25 September 2008

International Classifications

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

18 September 2008 Complete Application Filed

  Priority application(s): 09/321,522 27.05.99 US; 60/099,804 10.09.98 US

25 September 2008 Application Open to Public Inspection

  Published as AU-A-2008207703

27 November 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008207704-Elevator system having no machineroom

2008207702-Lockable differentials